Jump to Navigation

Advair Injuries

Synopsis of Prescription Drug Litigation

Advair and Serevent side effects could increase the risk of severe asthma attacks or asthma-related deaths, especially among children. The drugs are approved for use by adults and children as young as 4 for the long-term prevention of asthma. While these inhalers have been shown to decrease the number of asthma attacks, they could severely increase the severity of the attacks that do occur. As a result, there have been a number of reported deaths and hospitalizations directly associated with the use of Advair and Serevent.

Advair® (fluticasone and salmeterol): Manufactured by GlaxoSmithKline (GSK) and approved by the FDA in 2003, ADVAIR DISKUS is a combination steroid (fluticasone) that decreases inflammation in lung airways and a bronchodilator (salmeterol) that helps open constricted airways to help the patient breath. Salmeterol is in a class of drugs called Long-Acting Beta Agonist (LABA). The Diskus device is the delivery system for Advair. It delivers the drugs as a dry powder inhaler (DPI) that the patient orally inhales.

Why is this medication prescribed?: The combination of fluticasone and salmeterol is used to prevent wheezing, shortness of breath, and breathing difficulties caused by asthma and chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). Fluticasone is in a class of medications called steroids. It works by reducing swelling in the airways. Salmeterol is in a class of medications called long-acting beta-agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.

FDA indications: ADVAIR DISKUS is indicated for the treatment of asthma in patients aged 4 years and older. ADVAIR DISKUS 250/50 is also indicated for the twice-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. ADVAIR DISKUS 250/50 is also indicated to reduce exacerbations of COPD in patients with a history of exacerbations. ADVAIR DISKUS 250/50 twice daily is the only approved dosage for the treatment of COPD because an efficacy advantage of the higher strength ADVAIR DISKUS 500/50 over ADVAIR DISKUS 250/50 has not been demonstrated

What you should know before taking Advair:

  • tell your doctor and pharmacist if you are allergic to fluticasone (Flonase, Flovent), salmeterol (Serevent), any other medications, milk protein, or any foods.
  • tell your doctor if you use another LABA such as formoterol (Foradil) or salmeterol (Serevent). These medications should not be used with fluticasone and salmeterol inhalation. Your doctor will tell you which medication you should use and which medication you should stop using.
  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: antifungals such as fluconazole (Diflucan), itraconazole (Sporanox), and ketoconazole (Nizoral); beta-blockers such as atenolol (Tenormin), labetalol (Normodyne), metoprolol (Lopressor, Toprol XL), nadolol (Corgard), and propranolol (Inderal); cimetidine (Tagamet); clarithromycin (Biaxin); cyclosporine (Neoral, Sandimmune); danazol (Danocrine); delavirdine (Rescriptor); diltiazem (Cardizem, Dilacor, Tiazac); diuretics ('water pills'); fluoxetine (Prozac, Sarafem); fluvoxamine (Luvox); HIV protease inhibitors such as atazanavir (Reyataz), indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir), and saquinavir (Invirase); isoniazid (INH, Nydrazid); other medications for asthma or COPD; medications for seizures; metronidazole (Flagyl); nefazodone; oral contraceptives (birth control pills); telithromycin (Ketek); troleandomycin (TAO); verapamil (Calan, Covera, Isoptin, Verelan); and zafirlukast (Accolate). Also tell your doctor and pharmacist if you are taking the following medications or have stopped taking them during the past 2 weeks: antidepressants such as amitriptyline (Elavil), amoxapine (Asendin), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Adapin, Sinequan), imipramine (Tofranil), nortriptyline (Aventyl, Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil); and monoamine oxidase (MAO) inhibitors, including isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl), and tranylcypromine (Parnate). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
  • tell your doctor if you or anyone in your family has or has ever had osteoporosis (a condition in which the bones become weak and fragile), and if you have or have ever had high blood pressure, irregular heartbeat, seizures, hyperthyroidism (overactive thyroid), diabetes, tuberculosis (TB), glaucoma (an eye disease), any condition that affects your immune system, liver disease, or heart disease. Also tell your doctor if you have a herpes eye infection or any other type of infection and if you smoke or use tobacco products, if you do not eat a healthy diet, or if you do not exercise very often.
  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using fluticasone and salmeterol, call your doctor.
  • if you are having surgery, including dental surgery, tell your doctor or dentist that you are using fluticasone and salmeterol.
  • tell your doctor if you have never had chickenpox or measles and have not been vaccinated against these infections. Stay away from people who are sick, especially people who have chickenpox or measles. If you are exposed to these infections or if you develop symptoms of these infections, call your doctor immediately. You may need to get a vaccine (shot) to protect you from these infections.
  • Talk to your doctor about eating grapefruit or drinking grapefruit juice while taking this medication since there can be a potential interaction

Black Box  Warning:


WARNING: ASTHMA-RELATED DEATH
See full prescribing information for complete boxed warning.
  • Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, one of the active ingredients in ADVAIR DISKUS, may increase the risk of asthma-related death. A US study showed an increase in asthma-related deaths in patients receiving salmeterol (13 deaths out of 13,176 patients treated for 28 weeks on salmeterol versus 3 out of 13,179 patients on placebo). Currently available data are inadequate to determine whether concurrent use of inhaled corticosteroids or other long-term asthma control drugs mitigates the increased risk of asthma-related death from LABAs. Available data from controlled clinical trials suggest that LABAs increase the risk of asthma-related hospitalization in pediatric and adolescent patients. (5.1)
  • When treating patients with asthma, only prescribe ADVAIR DISKUS for patients not adequately controlled on a long-term asthma control medication, such as an inhaled corticosteroid, or whose disease severity clearly warrants initiation of treatment with both an inhaled corticosteroid and a LABA. Once asthma control is achieved and maintained, assess the patient at regular intervals and step down therapy (e.g., discontinue ADVAIR DISKUS) if possible without loss of asthma control and maintain the patient on a long-term asthma control medication, such as an inhaled corticosteroid. Do not use ADVAIR DISKUS for patients whose asthma is adequately controlled on low- or medium-dose inhaled corticosteroids. (1.1, 5.1)

Lawsuits: There have been several lawsuits launched on behalf of patients especially children, throughout the U.S. Some of these have been due to asthma related deaths and serious injury that involved one of the active ingredients in Advair and Serevent which is salmeterol. There have been reports of up to 4,000 fatalities linked to Advair/Serevent side effects.

When to call the Venardi Law Firm: If you have been damaged or hurt by the drug and need an Advair/Serevent attorney, call the Venardi Law Firm. Serious side effects as well as increased chances of severe asthma attacks to asthma-related deaths have occurred with patients using Advair or Serevent.



Click Here For Your Free Case Evaluation
Free Case Evaluation

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close
Recent Posts
Contact UsPrint Page

The Venardi Law Firm
2033 North Main Street, Suite 750
Walnut Creek CA 94596

Telephone: 925-478-5557
Telephone: 888-732-7047
Fax: 925-937-3905

Walnut Creek Law Office
Email the Firm

785 Market Street, 16th Floor
San Francisco, CA 94103
Telephone: 415-255-5638
San Francisco Law Office

790 Mission Avenue
San Rafael, CA 94901
Telephone: 510-270-5772
San Rafael Law Office

AV | LexisNexis Martindale-Hubbell | Peer Review Rated For Ethical Standards and Legal Ability

Mark Venardi has earned an AV rating by Martindale Hubbell every year since 2004. This is the highest achievement given by the peer review rating system.

Super Lawyers 2010

Mark was named a California Super Lawyer in 2009 and 2010.

Million Dollar Advocates Forum San Francisco Trial Lawyers Association Consumer Attorneys of California The American Trial Lawyers Association